Phase 2 Study of Orlistat and SLx-4090 for the Treatment of Type 1 Hyperlipoproteinemia
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT01675154 |
|
Recruitment Status :
Terminated
(Due to unavailability of the drug.)
First Posted : August 29, 2012
Last Update Posted : September 29, 2020
|
Sponsor:
University of Texas Southwestern Medical Center
Information provided by (Responsible Party):
Abhimanyu Garg, University of Texas Southwestern Medical Center
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Terminated |
|---|---|
| Actual Primary Completion Date : | June 30, 2020 |
| Actual Study Completion Date : | June 30, 2020 |